Table 2. First-line therapy and CR rates... | American Society of Hematology

Table 2.

First-line therapy and CR rates stratified according to disease stage at presentation

Ann Arbor stage	First-line therapy	Number of patients (174)*	CR	Relapse or progression type†
Ann Arbor stage	First-line therapy	Number of patients (174)*	CR	Systemic	Local	Combined
I	RT only	111	108	17	2	3
	RT + other‡	12	11	2	1	0
	Chemotherapy	7	7	1	1	0
	Other‡	12	6	1	3	0

II	RT only	2	2	1	0	0
	RT + other	1	1	0	0	0
	Chemotherapy	1	0	0	0	0
	Other	1	1	0	0	0

III	RT + other	1	0	1	0	0
	Chemotherapy only	3	0	0	2	0
	Other	5	1	1	1	0

IV	RT only	4	0	3	0	0
	RT + other	5	5	3	0	1
	Chemotherapy only	4	2	0	2	0
	Other	3	2	0	2	0

Ann Arbor stage	First-line therapy	Number of patients (174)*	CR	Relapse or progression type†
Ann Arbor stage	First-line therapy	Number of patients (174)*	CR	Systemic	Local	Combined
I	RT only	111	108	17	2	3
	RT + other‡	12	11	2	1	0
	Chemotherapy	7	7	1	1	0
	Other‡	12	6	1	3	0

II	RT only	2	2	1	0	0
	RT + other	1	1	0	0	0
	Chemotherapy	1	0	0	0	0
	Other	1	1	0	0	0

III	RT + other	1	0	1	0	0
	Chemotherapy only	3	0	0	2	0
	Other	5	1	1	1	0

IV	RT only	4	0	3	0	0
	RT + other	5	5	3	0	1
	Chemotherapy only	4	2	0	2	0
	Other	3	2	0	2	0

Two patients did not have staging and received surgical treatment, with 1 patient achieving CR.

Number of relapses or progression in all patients irrespective of the response to first-line therapy.

For details, see supplemental Table 2.